NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report)’s stock price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.56 and traded as low as $0.56. NovaBay Pharmaceuticals shares last traded at $0.58, with a volume of 20,497 shares.
NovaBay Pharmaceuticals Stock Performance
The firm’s fifty day simple moving average is $0.56. The stock has a market cap of $2.44 million, a PE ratio of -0.06 and a beta of 2.82.
NovaBay Pharmaceuticals Company Profile
NovaBay Pharmaceuticals, Inc develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health.
Further Reading
- Five stocks we like better than NovaBay Pharmaceuticals
- What is a support level?
- Five Below Pops on Strong Earnings, But Rally May Stall
- Trading Halts Explained
- Intel’s Dual Gamble: AI Innovation Now, Foundry Fortunes Later?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- X: 1 Reason to Bet on U.S. Steel, and 1 Reason to Hold Back
Receive News & Ratings for NovaBay Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovaBay Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
